Tangkiatkumjai M, Boardman H, Walker DM. Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review. BMC Complement Med Ther. 2020;20(1):363. https://doi.org/10.1186/s12906-020-03157-2.
Article PubMed PubMed Central Google Scholar
Purohit MP, Wells RE, Zafonte RD, Davis RB, Phillips RS. Neuropsychiatric symptoms and the use of complementary and alternative medicine. PM R. 2013;5(1):24–31. https://doi.org/10.1016/j.pmrj.2012.06.012.
Traditional medicine. https://www.who.int/news-room/questions-and-answers/item/traditional-medicine. Accessed 06 June 2024.
Asher GN, Gerkin J, Gaynes BN. Complementary therapies for mental health disorders. Med Clin North Am. 2017;101(5):847–64. https://doi.org/10.1016/j.mcna.2017.04.004.
Ravindran AV, Balneaves LG, Faulkner G, Ortiz A, McIntosh D, Morehouse RL, et al. Canadian Network for Mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Sect. 5. Complementary and alternative medicine treatments. Can J Psychiatry. 2016;61(9):576–87. https://doi.org/10.1177/0706743716660290.
Article PubMed PubMed Central Google Scholar
Barić H, Đorđević V, Cerovečki I, Trkulja V. Complementary and alternative medicine treatments for generalized anxiety disorder: systematic review and Meta-analysis of Randomized controlled trials. Adv Ther. 2018;35(3):261–88. https://doi.org/10.1007/s12325-018-0680-6.
Carlson LE, Ismaila N, Addington EL, Asher GN, Atreya C, Balneaves LG et al. Integrative Oncology Care of symptoms of anxiety and depression in adults with Cancer: Society for Integrative Oncology-ASCO Guideline. J Clin Oncol 2023:4562–91. https://doi.org/10.1200/JCO.23.00857.
Crone CC, Wise TN. Survey of alternative medicine use among organ transplant patients. J Transpl Coord. 1997;7(3):123–30. https://doi.org/10.7182/prtr.1.7.3.j651880137772172.
Article CAS PubMed Google Scholar
Osman NA, Hassanein SM, Leil MM, NasrAllah MM. Complementary and alternative medicine use among patients with chronic kidney disease and kidney transplant recipients. J Ren Nutr. 2015;25(6):466–71. https://doi.org/10.1053/j.jrn.2015.04.009.
Matthees BJ, Anantachoti P, Kreitzer MJ, Savik K, Hertz MI, Gross CR. Use of complementary therapies, adherence, and quality of life in lung transplant recipients. Heart Lung. 2001;30(4):258–68. https://doi.org/10.1067/mhl.2001.116135.
Article CAS PubMed Google Scholar
Henson JB, Brown CL, Chow SC, Muir AJ. Complementary and alternative medicine use in United States adults with liver disease. J Clin Gastroenterol. 2017;51(6):564–70. https://doi.org/10.1097/MCG.0000000000000617.
Article PubMed PubMed Central Google Scholar
Neff GW, O’Brien C, Montalbano M, DeManno A, Kahn S, Safdar K, et al. Consumption of dietary supplements in a liver transplant population. Liver Transpl. 2004;10(7):881–85. https://doi.org/10.1002/lt.20183.
Tickerhoof L, Wagener MM, Cacciarelli TV, Singh N. Alternative therapy use in liver transplant recipients. Prog Transplantation. 2006;16(3):226–31. https://doi.org/10.1177/152692480601600307.
Heinrich TW, Marcangelo M. Psychiatric issues in solid organ transplantation. Harv Rev Psychiatry 2009:17(6): 398–406. https://doi.org/10.3109/10673220903463259.
Faeder S, Moschenross D, Rosenberger E, Dew MA, DiMartini A. Psychiatric aspects of organ transplantation and donation. Curr Opin Psychiatry. 2015;28(5):357–64. https://doi.org/10.1097/YCO.0000000000000185.
Article PubMed PubMed Central Google Scholar
Navarro VJ, Barnhart H, Bonkovsky HL, Davern T, Fontana RJ, Grant L, et al. Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology. 2014;60(4):1399–408. https://doi.org/10.1002/hep.27317.
Wong LL, Lacar L, Roytman M, Orloff SL. Urgent liver transplantation for dietary supplements: an under-recognized problem. Transpl Proc. 2017;49(2):322–25. https://doi.org/10.1016/j.transproceed.2016.11.041.
Hillman L, Gottfried M, Whitsett M, Rakela J, Schilsky M, Lee WM et al. Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury. Am J Gastroenterol 2016: 111(7):958–65. https://doi.org/10.1038/ajg.2016.114.
Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148(7):1340–52. .e7.
Francis P, Navarro VJ. Drug-Induced Hepatotoxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. https://www.ncbi.nlm.nih.gov/books/NBK557535/. Accessed May 2, 2024.
Fontana RJ, Liou I, Reuben A, Suzuki A, Fiel MI, Lee W et al. AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury. Hepatology. 2023: 1;77(3):1036-65. Practice guidance with expert opinion-based recommendations regarding recognition, risk-stratification, and management of drug-induced liver injury.
Voican CS, Corruble E, Naveau S, Perlemuter G. Antidepressant-induced liver injury: a review for clinicians. Am J Psychiatry. 2014;171(4):404–15. https://doi.org/10.1176/appi.ajp.2013.13050709.
Gunther M, Dopheide JA. Antipsychotic safety in liver disease: a narrative review and practical guide for the clinician. J Acad Consult Liaison Psychiatry. 2023;64(1):73–82. https://doi.org/10.1016/j.jaclp.2022.09.006.
Todorović Vukotić N, Đorđević J, Pejić S, Đorđević N, Pajović SB. Antidepressants- and antipsychotics-induced hepatotoxicity. Arch Toxicol. 2021;95(3):767–89. https://doi.org/10.1007/s00204-020-02963-4.
Article CAS PubMed PubMed Central Google Scholar
Savage K, Firth J, Stough C, Sarris J. GABA-modulating phytomedicines for anxiety: a systematic review of preclinical and clinical evidence. Phytother Res. 2018;32(1):3–18. https://doi.org/10.1002/ptr.5940.
Article CAS PubMed Google Scholar
Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study. Med (Baltim). 2019;98(37):e17186. https://doi.org/10.1097/MD.0000000000017186.
Deshpande A, Irani N, Balkrishnan R, Benny IR. A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults. Sleep Med. 2020;72:28–36. https://doi.org/10.1016/j.sleep.2020.03.012.
Gopukumar K, Thanawala S, Somepalli V, Rao TSS, Thamatam VB, Chauhan S. Efficacy and safety of Ashwagandha Root Extract on cognitive functions in healthy, stressed adults: a Randomized, Double-Blind, placebo-controlled study. Evid Based Complement Alternat Med. 2021;20218254344. https://doi.org/10.1155/2021/8254344.
Björnsson HK, Björnsson ES, Avula B, Khan IA, Jonasson JG, Ghabril M, et al. Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020;40(4):825–29. https://doi.org/10.1111/liv.14393.
Article CAS PubMed PubMed Central Google Scholar
Philips CA, Valsan A, Theruvath AH, Ravindran R, Oommen TT, Rajesh S, et al. Ashwagandha-induced liver injury-A case series from India and literature review. Hepatol Commun. 2023;7(10):e0270. https://doi.org/10.1097/HC9.0000000000000270.
Article PubMed PubMed Central Google Scholar
Suryawanshi G, Abdallah M, Thomson M, Desai N, Chauhan A, Lim N. Ashwagandha-associated acute liver failure requiring liver transplantation. Am J Ther. 2023;30(1):e80–3. https://doi.org/10.1097/MJT.0000000000001466.
Rothenberg DO, Zhang L. Mechanisms underlying the anti-depressive effects of regular tea consumption. Nutrients. 2019;11(6):1361. https://doi.org/10.3390/nu11061361.
Article CAS PubMed PubMed Central Google Scholar
Mancini E, Beglinger C, Drewe J, Zanchi D, Lang UE, Borgwardt S. Green tea effects on cognition, mood and human brain function: a systematic review. Phytomedicine. 2017;34:26–37. https://doi.org/10.1016/j.phymed.2017.07.008.
Article CAS PubMed Google Scholar
Oketch-Rabah HA, Roe AL, Rider CV, Bonkovsky HL, Giancaspro GI, Navarro V et al. United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts. Toxicol Rep 2020:7:386–402. https://doi.org/10.1016/j.toxrep.2020.02.008.
Acosta L, Byham-Gray L, Kurzer M, Samavat H. Hepatotoxicity with high-dose green tea extract: Effect of Catechol-O-Methyltransferase and Uridine 5’-Diphospho-glucuronosyltransferase 1A4 genotypes. J Diet Suppl. 2023;20(6):850–69. https://doi.org/10.1080/19390211.2022.2128501.
留言 (0)